Lymphoma, T-Cell

• 

  Subject Areas on Research

  • A potential therapeutic application of SET/I2PP2A inhibitor OP449 for canine T-cell lymphoma. 
  • A small cell variant of ALK-positive, CD8-positive anaplastic large cell lymphoma with primary subcutaneous presentation mimicking subcutaneous panniculitis-like T-cell lymphoma. 
  • Abnormalities of circulating T-cell subpopulations in patients with cutaneous T-cell lymphoma: cutaneous lymphocyte-associated antigen expression on T cells correlates with extent of disease. 
  • Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma. 
  • Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas. 
  • Cells treated with TAP-2 antisense oligonucleotides are potent antigen-presenting cells in vitro and in vivo. 
  • Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma. 
  • Clinical and histopathologic overlap between subcutaneous panniculitis-like T-cell lymphoma with systemic features and small cell CD8+ ALK+ systemic anaplastic large cell lymphoma with cutaneous involvement. 
  • Composite lymphoid neoplasm of B-cell and T-cell origins: a pathologic study of 14 cases. 
  • Diagnosis of gastrointestinal T-cell lymphomas in routinely processed tissues. 
  • Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis. 
  • Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients. 
  • Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Review With an Emphasis on Diagnostic Differentiation From Other T-Cell/Natural Killer-Cell Neoplasms. 
  • Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review. 
  • Hepatosplenic T-cell lymphoma with blastoid morphology in a patient with Crohn disease. 
  • Hepatosplenic T-cell lymphoma: an unusual case of a gamma delta T-cell lymphoma with a blast-like terminal transformation. 
  • High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. 
  • Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. 
  • Immunophenotypic and diagnostic characterization of angioimmunoblastic T-cell lymphoma by advanced flow cytometric technology. 
  • Induction of apoptosis by the novel retinoid AHPN in human T-cell lymphoma cells involves caspase-dependent and independent pathways. 
  • Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. 
  • Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma. 
  • Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides. 
  • Methylobacterium mesophilica as a cause of persistent bacteremia in a child with lymphoma. 
  • Mitochondrial dysfunction in ataxia-telangiectasia. 
  • Molecular evidence of a genotypically novel large T-cell lymphoma after anti-CD4 therapy for refractory mycosis fungoides. 
  • NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021. 
  • NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018. 
  • Ophthalmic findings in a patient with CD8-positive T cell lymphoma and a hydroa vacciniforme-like eruption. 
  • PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. 
  • Perianal ulceration. A novel manifestation of angiocentric lymphoma. 
  • Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. 
  • Post transplant CD8+ gammadelta T-cell lymphoma associated with human herpes virus-6 infection. 
  • Primary testicular natural killer/T-cell lymphoma: A CARE-case report and review of literature. 
  • Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases. 
  • Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma. 
  • Subcutaneous panniculitis-like T-cell lymphoma in a 25-year-old male patient with sickle cell disease. 
  • T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. 
  • T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. 
  • The Genetic Basis of Hepatosplenic T-cell Lymphoma. 
  • The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma. 
  • Update on the Classification of and Diagnostic Approaches to Mature T-Cell Lymphomas. 
  • WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. 
• 

  Keywords of People

  • Stefanovic, Alexandra, Associate Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy
  • Stoecker, Maggie Marie, Assistant Professor of Pathology, Pathology